Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Lixte Biotechnology Holdings (LIXT) Assets Average (2016)

Lixte Biotechnology Holdings' Assets Average history spans 6 years, with the latest figure at $1.2 million for Q3 2016.

  • For Q3 2016, Assets Average fell 9.4% year-over-year to $1.2 million; the TTM value through Sep 2016 reached $1.2 million, down 9.4%, while the annual FY2015 figure was $578007.5, N/A changed from the prior year.
  • Assets Average reached $1.2 million in Q3 2016 per LIXT's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $2.1 million in Q3 2012 to a low of $315670.5 in Q1 2012.
  • Average Assets Average over 5 years is $1.2 million, with a median of $1.2 million recorded in 2012.
  • Peak YoY movement for Assets Average: skyrocketed 412.26% in 2013, then crashed 76.94% in 2014.
  • A 5-year view of Assets Average shows it stood at $1.9 million in 2012, then plummeted by 61.45% to $715930.5 in 2013, then skyrocketed by 60.52% to $1.1 million in 2014, then decreased by 29.3% to $812520.5 in 2015, then surged by 42.29% to $1.2 million in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Assets Average are $1.2 million (Q3 2016), $1.3 million (Q2 2016), and $911339.0 (Q1 2016).